Sigyn Therapeutics, Inc.
SIGY · OTCMCIK 1642159fmd_0WC5PW4B21P013ZZ2257AK2G30Manufacturing · Surgical & Medical Instruments & ApparatusTemplate: Standard
Coverage: Jan 01, 2014 to Sep 30, 2025, 45 periods
| Line item | FY2014 | FY2015 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenues | 0 | 0 | 0 | 0 | 0 | – | – | – | – | – |
| Cost of revenue | 0 | 0 | 0 | 0 | 0 | – | – | – | – | – |
| Gross profit | 0 | 0 | 0 | 0 | 0 | – | – | – | – | – |
| Research and development | – | – | – | – | – | 0 | 1 | 1 | 1 | 1 |
| Total operating expenses | 0 | 2 | 2 | 1 | 1 | 1 | 2 | 2 | 2 | 3 |
| Operating income | (0) | (2) | (2) | (1) | (1) | (1) | (2) | (2) | (2) | (3) |
| Interest expense | – | (0) | 1 | 0 | 0 | 0 | 0 | – | – | – |
| Other non-operating income (expense) | – | 0 | (2) | (1) | (3) | (0) | (1) | (1) | (2) | (1) |
| Income before taxes | (0) | (3) | (4) | (2) | (3) | (1) | (3) | (3) | (4) | (3) |
| Income tax expense | – | – | 0 | 0 | – | – | – | – | – | – |
| Net income from continuing operations | – | – | (4) | (2) | (3) | – | – | – | – | – |
| Net income | (0) | (3) | (4) | (3) | (3) | (1) | (3) | (3) | (4) | (3) |